Form D · Venture Capital Fund

BioInnovation Capital I LP

Cambridge, MA · CIK 0001660831

Offering snapshot reported Feb 15, 2017 · SEC filing

Reported sold: $65.6M
Investors reported: 12
Minimum accepted: $0
First sale: Feb 23, 2016

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 12

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 15, 2017	Amendment	$65,625,000	No comparison	12	SEC filing
Feb 4, 2016	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0
Form D file number: 021-256777

Sales commissions to the placement agent will be equal to a percentage of the aggregate principal amount of securities sold.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
XT Capital Partners, LLC	118719

Source: Form D, filed Feb 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOINNOVATION CAPITAL I LP

Investment adviser: BIOINNOVATION MANAGEMENT LLC

Gross asset value: $211M
Beneficial owners: 37
ADV minimum commitment: $500K

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CARTA INVESTOR SERVICES SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP BOSTON, Massachusetts, United States

Custodian CITIZENS BANK RIVERSIDE, Rhode Island, United States Related to adviser: No

Custodian FIRST CITIZENS BANCSHARES RALEIGH, North Carolina, United States Related to adviser: No

Marketer XT CAPITAL PARTNERS, LLC WESTPORT, Connecticut, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG LLP
PCAOB 185

XT CAPITAL PARTNERS, LLC
CRD 118719 · SEC 8-53683

Filing source

Form ADV 2056302 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-1499811658

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
General Partner Bio Innovation Capital I Gp Llc	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1 Broadway 14 Th Floor
Cambridge, MA, 02142